Jefferies initiates coverage of Teradyne with buy rating and $284 price target
TER•Jefferies initiated coverage of Teradyne with a buy rating and a $284 price target.
Related News
aTyr Pharma plans participation in Jefferies and Piper Sandler healthcare conferences
ATYR•
Six Flags names Adam Boal chief procurement officer
FUN•
Virtus Investment Partners AUM falls to $134 billion in October
VRTS•
Inovio plans participation in Jefferies and Piper Sandler healthcare conferences
INO•
Citius Pharmaceuticals attends Jefferies Healthcare Conference
CTXR•